Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $650.00

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by Royal Bank Of Canada from $625.00 to $650.00 in a report published on Wednesday morning, MarketBeat reports. Royal Bank Of Canada currently has an outperform rating on the medical equipment provider’s stock.

Several other brokerages have also recently commented on ISRG. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $685.00 price target on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Daiwa Capital Markets boosted their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn raised their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Stock Up 1.9%

ISRG stock opened at $572.47 on Wednesday. The company has a 50-day simple moving average of $541.48 and a 200 day simple moving average of $506.30. The company has a market capitalization of $205.22 billion, a P/E ratio of 75.72, a PEG ratio of 5.16 and a beta of 1.68. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the company earned $1.84 EPS. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 22,806 shares of the firm’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $570.89, for a total value of $13,019,717.34. Following the sale, the insider owned 2,694 shares of the company’s stock, valued at $1,537,977.66. The trade was a 89.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently made changes to their positions in the company. Aaron Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares during the last quarter. Prosperity Consulting Group LLC grew its position in shares of Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares during the last quarter. Evergreen Capital Management LLC increased its stake in shares of Intuitive Surgical by 0.5% in the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after purchasing an additional 20 shares during the period. Rise Advisors LLC increased its stake in shares of Intuitive Surgical by 5.6% in the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares during the period. Finally, Rossmore Private Capital lifted its position in shares of Intuitive Surgical by 2.0% during the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.